DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20180855

Oral diclofenac potassium versus hyoscine-N-butyl bromide for pain relief during copper intrauterine device insertion: randomized clinical trial

Ahmed M. Abbas, Mohammed F. Abdel-Ghany, Nadia Abdullah Mohammed, Mostafa Khodry, Armia Michael, Laila E. Abdelfatah, Hosam Ramadan

Abstract


Background: Present study was carried out to compare the analgesic effect of oral diclofenac potassium versus hyoscine-N-butyl bromide (HBB) for pain relief during copper intrauterine device (IUD) insertion.

Methods: It was a a randomized clinical trial carried out at Assiut University Hospital, Assiut, Egypt. Parous women eligible for Copper IUD insertion were recruited and randomized in a 1:1 ratio to diclofenac potassium or HBB. The participants were asked to take 2 tablets of the study medications 30 minutes before IUD insertion. The primary outcome was the participant's self-rated pain perception using a 10-cm Visual Analogue Scale (VAS) during IUD insertion. We considered a 1.5 cm difference in VAS scores between study groups as clinically significant.

Results: One hundred eight women were enrolled (n=54 in each group). Diclofenac significantly has lower mean pain score during speculum placement (1.73 vs. 2.13) and tenaculum placement (1.85 vs. 2.3) than HBB with p<0.001. No statistical significant differences between both groups in other steps of IUD insertion. Additionally, the duration of IUD insertion was significantly lower in the diclofenac group (5.34±0.76 vs. 5.74±1.23 minutes, p=0.045). No women reported side effects in both groups.

Conclusions: The use of oral diclofenac potassium 30 minutes prior to copper IUD insertion slightly reduce the insertional pain and duration than oral HBB with no adverse effects.


Keywords


Contraception, Diclofenac potassium, Hyoscine-N-butyl bromide, Intrauterine device

Full Text:

PDF

References


Kulier R, O'Brien PA, Helmerhorst FM, Usherpatel M, D'Arcangues C. Copper containing framed IUDs for contraception. Cochrane Database Syst Rev. 2007;4:CD005347.

Allen RH, Goldberg AB, Grimes DA. Expanding access to intrauterine contraception. Am J Obstet Gynecol. 2009;201:451-5.

Weston MR, Martins SL, Neustadt AB, Giliam ML. Factors influence uptake of IUDs among postpartum adolescents: a qualitative study. Am J Obstet Gynecol. 2012;206:40.e1-40.e7.

Hubacher D, Reyes V, Lillo S, Zepeda A, Chen PL, Croxatto H. Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. Am J Obstet Gynecol. 2006;195:1272-7.

Ahmed MA, Abdelrahman MA, Ahmed HE, Shaimaa A, Mohamed SF. Rectal indomethacin is an effective analgesic during copper T380A intrauterine device insertion: A randomized double-blind placebo-controlled trial. Glob J Reprod Med. 2017;2(1):555576.

Khalaf M, Amin AF, Sayed Z, El-Nashar IM, Abbas AM. A randomized double-blind controlled trial of two different doses of self-administered vaginal misoprostol for successful copper intrauterine device insertion, Middle East Fertil Soc J. 2017;22(4):264-8.

Abdellah MS, Abbas AM, Hegazy AM, El-Nashar IM. Vaginal misoprostol prior to intrauterine device insertion in women delivered only by elective cesarean section: a randomized double-blind clinical trial. Contraception. 2017 Jun;95(6):538-43.

Abbas AM, Abdellah MS, Khalaf M, Bahloul M, Abdellah NH, Ali MK, et al. Effect of cervical lidocaine-prilocaine cream on pain perception during copper T380A intrauterine device insertion among parous women: A randomized double-blind controlled trial. Contraception. 2017;95(3):251-6.

Lopez LM, Bernholc A, Zeng Y, Allen RH, Bartz D, O’Brien PA, et al. Interventions for pain with intrauterine device insertion. Cochrane Database Syst Rev. 2015;29;7:CD007373.

Derry C, Derry S, Moore RA, McQuay HJ. Single dose oral naproxen and naproxen sodium for acute postoperative pain in adults. Cochrane Database Syst Rev. 2009;21(1):CD004234.

Mason L, Edwards JE, Moore RA, McQuay HJ. Single-dose oral naproxen for acute postoperative pain: a quantitative systematic review. BMC Anesthesiol. 2003;3:4.

Hotwani J, Ainapure SS. Hyoscine butylbromide suppositories. Indian Med Gaz. 2000;1:217-9.

Papadopoulos G, Bourdoumis A, Kachrilas S, Bach C, Buchhloz N, Masood J. Hyoscine Nbutylbromide (Buscopan®) in the treatment of acute ureteral colic:what is the evidence? Urol Int. 2014;92:253-7.

Jareethum R, Suksompong S, Petyim S, Prechapanich J, Laokirkkiat P, Choavaratana R. Efficacy of mefenamic acid and hyoscine for pain relief during saline infusion sonohysterography in infertile women: a double blind randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2011;155:193-8.

Moro F, Selvaggi L, Sagnella F, Morciano A, Martinez D, Gangale MF et al. Could antispasmodic drug reduce pain during hysterosalpingo-contrast sonography (HyCoSy) in infertile patients? A randomized double-blind clinical trial. Ultrasound Obstet Gynecol. 2012;39:260-5.

Abbas AM, Abo-Elela NA, Mosa EM. Effect of oral hyoscine-N-butyl bromide on pain perception during hysterosalpingography: a randomized, double-blind, placebo-controlled trial. Middle East Fertil Soc J. 2017 (Article in press).

World Health Organization. Medical Eligibility Criteria for Contraceptive Use. Geneva (Switzerland): WHO; 2010.

Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114(1-2):29-36.

Bednarek PH, Creinin MD, Reeves MF, Cwiak C, Espey E, Jensen JT, et al. Prophylactic ibuprofen does not improve pain with IUD insertion: a randomized trial. Contraception. 2015;91:193-7.

Rowbotham MC. What is a ‘clinically meaningful’ reduction in pain? Pain. 2001;94:131-2.

Potter J, Rubin SE, Sherman P. Fear of intrauterine contraception among adolescents in New York City. Contraception 2014;89:446-50.

Karabayirli S, Ayrim AA, Muslu B. Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. J Minim Invasive Gynecol. 2012;19:581-4.

Fouda UM, Salah Eldin NM, Elsetohy KA, Tolba HA, Shaban MM, Sobh SM. Diclofenac plus lidocaine gel for pain relief during intrauterine device insertion. A randomized double blinded placebo-controlled study. Contraception. 2016;93(6):513-8.

Abbas AM, Wagdy WM, Salem MN, Abdelqader AM. Effect of oral diclofenac potassium plus cervical lidocaine cream on pain perception during hysterosalpingography: a randomized, double-blind, placebo-controlled trial. Middle East Fertil Soc J. 2017 (Article in press).